CIK 0001422142
- Non-accelerated filer
- Smaller reporting company
Whitehawk Therapeutics, Inc.
Sign in to watch- Ticker
- WHWK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547850
- Phone
- +1 551-321-2234
- Business address
- 2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
- Former names
- Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
- 4 Open-market buy Director bought 762,995 shares at $5.00 ($3,814,975)
- 4 Open-market buy Chief Scientific Officer bought 3,642 shares at $5.00 ($18,210)
- 4 Open-market buy Director bought 762,995 shares at $5.00 ($3,814,975)
- 4 Open-market buy Director bought 99,996 shares at $5.00 ($499,980)
- 4 Open-market buy Director bought 272,302 shares at $5.00 ($1,361,510)
- 4 Open-market buy 10% owner bought 560,000 shares at $5.00 ($2,800,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 1,120,000 shares at $5.00 ($5,600,000)
- 3 Insider Initial Statement of Ownership
Page 13 of 14 · 263 filings